Cancer Genetics Announces Participation at the 22nd Annual Rodman & Renshaw Global Investment Conference

On September 10, 2020 Cancer Genetics, Inc. (the "Company") (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, reported it will present at the 22nd Annual Rodman & Renshaw Global Investment Conference sponsored by H.C. Wainwright & Co., LLC. The conference is being held virtually from September 14-16, 2020 (Press release, Cancer Genetics, SEP 10, 2020, View Source [SID1234564933]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event: 22nd Annual Rodman & Renshaw Global Investment Conference
Date: September 16, 2020
Time: 11:30am ET
Conference Details: www.rodmanevents.com

Cancer Genetics’ management team will provide an overview of the Company’s business and scientific advancements during the live presentation and will be available to participate in one-on-one virtual meetings with investors who are registered to attend the conference. Management will also be available for virtual investor meetings outside the conference.

If you are an institutional investor and would like to attend the Company’s presentation, please click on the following link (www.rodmanevents.com) to register for the Rodman & Renshaw conference. Once your registration is confirmed, you will be prompted to log into the conference website and also be able to request a one-on-one meeting with the Company.

For further information about attending the Company’s presentation or to book an individual appointment with Cancer Genetics’ management, please contact Jennifer K. Zimmons, Ph.D., at +1 917.214.3514 or [email protected].

To see the full list of upcoming events where the Company intends to present or participate, please visit Cancer Genetics’ web site under Events & Presentations.